| AA | Amyloid A amyloidosis |
| AL | Light chain amyloidosis |
| ATTR | Transthyretin amyloidosis |
| DN | Diabetic Nephropathy |
| ESRD | End-stage renal disease |
| GFR | Glomerular filtration rate |
| GBM | Glomerular basement membrane |
| UACR | Urine albumin–creatinine ratio |
| NGAL | Neutrophil gelatinase-associated lipocalin |
| KIM-1 | Kidney injury molecule-1 |
| GLP-1 | Glucagon-like peptide-1 |
| Th1 | T-helper 1 |
| ROS | Reactive oxygen species |
| TGF-β1 | Transforming Growth Factor Beta-1 |
| MCP-1 | Monocyte chemoattractant protein |
| IL-1 | Interleukin-1 |
| ILK | Integrin-linked kinase |
| TNF-α | Tumor Necrosis Factor-alpha |
| USF1 | Upstream Stimulatory Factor 1 |
| NFκB | Nuclear factor kappa B |
| MAPK | Mitogen-Activated Protein Kinase |
| PRRs | Pattern Recognition Receptors |
| PAMPS | Pathogen-associated molecular patterns |
| AGEs | Advanced-glycation end products |
| RAGE | Receptors for advanced glycation end-products |
| JAK/STAT | Janus kinase/signal transducer and activator of transcription |
| HDL | High-density lipoprotein |
| GAGs | Glycosaminoglycans |
| MMP | Matrix metalloproteinase |
| COX-2 | Cyclooxygenase-2 |
| PDX | Pyridoxamine |
| CRP | C-reactive protein |